AKBA
#3493
Akebia Therapeutics, Inc. - Common Stock
0.9 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.10%
Monthly Change
-27.42%
6 month change
-28.00%
Year Change
-23.73%
Previous Close
0.9 1
Open
0.8 9
Low
0.8 9
High
0.9 1
Volume
1 309
Financials
- Market Capitalization 249.4 M
- Employee 194
- Founded 2007
- CEO N/A
- Website www.akebia.com
- Headquarter Delaware, United States
- FIGI BBG000R33R00
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-80.5
Price to sales ratio
1.75
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3374 |  INCR Intercure Ltd. - ordinary shares | 5.39 USD | +534.12% | +450.00% | +498.89% | +224.70% | 294.73 M USD | ||
| 3446 |  EBS Emergent BioSolutions Inc. Common Stock | 5.18 USD | +1.77% | +15.62% | -29.52% | -51.68% | 265.60 M USD | ||
| 3525 |  ACB Aurora Cannabis Inc. - Common Shares | 3.94 USD | 0.00% | +9.44% | +45.93% | -21.20% | 232.25 M USD | ||
| 3573 |  ORGO Organogenesis Holdings Inc. - Class A | 1.66 USD | -7.78% | -3.49% | -31.12% | -61.31% | 213.60 M USD |
Frequently asked questions about Akebia Therapeutics, Inc.
What is the Akebia Therapeutics, Inc. stock price today?
The current price of Akebia Therapeutics, Inc. (AKBA) is 0.9. Over the past 24 hours, the stock has changed by -1.10%. Follow the AKBA chart for real-time price dynamics.
What is the stock ticker of Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. trades under the ticker AKBA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Akebia Therapeutics, Inc. stock going up?
AKBA has changed by +4.65% over the last week, -27.42% over the last month, and -23.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. currently has a market capitalization of 249.4 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Akebia Therapeutics, Inc. earnings last quarter?
Last quarter, Akebia Therapeutics, Inc. reported earnings of -0.03 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Akebia Therapeutics, Inc. revenue for the last quarter?
Akebia Therapeutics, Inc. reported quarterly revenue of 49.13 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Akebia Therapeutics, Inc. net income for the last quarter?
Akebia Therapeutics, Inc. reported net income of -8.91 M for the last quarter. The previous quarter showed -9.05 M, which means net income changed by +1.61%.
How many employees does Akebia Therapeutics, Inc. have?
As of the latest available data, Akebia Therapeutics, Inc. has 194 employees. Workforce size can provide additional context about the company's scale and operations.
What is Akebia Therapeutics, Inc. EBITDA?
Akebia Therapeutics, Inc. EBITDA is -5.74 M, and its EBITDA margin is -11.69%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Akebia Therapeutics, Inc. stock?
You can buy Akebia Therapeutics, Inc. (AKBA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Akebia Therapeutics, Inc. stock?
Investing in Akebia Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKBA chart and related analysis on metatrader.com as part of your research.